Real world effectiveness, persistence, tolerability, and safety of ofatumumab in clinical practice
{{output}}
Aims: To describe the 12-month effectiveness, persistence, tolerability, and safety of ofatumumab (OMB), a highly effective disease-modifying therapy (DMT) for relapsing multiple sclerosis (MS), in a real-world MS population. ... ...
